Goldman Sachs Global Health & Biotech - Managed Fund

Fund Performance Comparison

Relative Fund Performance vs {{ fund.benchmark.peers.peerCount }} peers using {{ fund.benchmark.name }} as their benchmark.

{{ fund.name }}
Peers
Benchmark ({{ fund.benchmark.name }})
{{ fund.model.name }}
The performance of the peers is calculated as the total of the performance for each time period for all the funds in the peer group, divided by the number of funds in the peer group.

Fees Comparison

{{ fund.fees * 100 | number:2 }}
% p.a.
{{ fund.name }}
{{ modelPortfolio.mer * 100 | number:2 }}
% p.a.
{{ modelPortfolio.name }}
{{ fund.benchmark.peers.mer * 100 | number:2 }}
% p.a.
Average of peers ({{ fund.benchmark.peers.peerCount }})
NOTE: Fee data has been provided by Morningstar, it may not include all costs being charged on your investment such as platform and adviser fees. You should check your fund manager or adviser statements to find out the exact fees you are being charged. Peers are funds that use the same benchmark in the Morningstar database.

Don't let high fees kill your returns

The {{ modelPortfolio.name }} portfolio has fair and transparent fees to help you keep more money in your pocket.

View our Fund

Don't let high fees kill your returns

Build a diversified portfolio to match your needs with our range of low cost investment options.

View our funds

Fund performance

  1M 3M 6M 1Y p.a. 2Y p.a. 3Y p.a. 5Y p.a. 10Y p.a.
Total return 3.12 5.32 10.31 7.95 3.56 -4.79 1.7 -
Growth return 3.12 5.32 10.31 7.95 3.56 -4.79 1.7 -
Income return 0 0 0 0 0 0 0 -
Market index (MSCI World NR AUD)
Total return 2.02 4.6 - 9.24 14.79 14.94 12.91 11.98
As as 31 Mar 2010. Returns for periods greater than 1 year are annualised. All figures are percentages.

Asset Allocation

Goldman Sachs Global Health & Biotech
International Equities
98.41%
Cash
1.59%
Australian Equities
0%
Property
0%
Fixed Interest
0%
Average Allocation of Peers
International Equities
84.93%
Cash
7.31%
Australian Equities
4.16%
Property
3.59%
Fixed Interest
0.01%

General Information

Fund Details
Type Description
Goldman Sachs Global Health & Biotech
Closed
Goldman Sachs Australia Managed Fds Ltd.
JBW0109AU
Equity World Other
Not Rated
Investment Fund
28 Jul 2000
$8.6 million (as at 31 Mar 2010)
$0.9966 (as at 21 Apr 2010)
$0.9544 (as at 21 Apr 2010)
Fund Objective
To achieve long-term capital growth by investing in healthcare: biotechnology and related companies globally. In doing so, the Fund aims to outperform the S&P GSSI Health Care Index in A$ over rolling three-year periods. The Fund invests in an underlying pooled fund, the Goldman Sachs JBWere Global Health & Biotech Pooled Fund.
Fund Strategy
The Fund invests in securities of companies across the major sub-sectors of the healthcare and biotech industry. Some representation is typically maintained in each major sub-sector of the healthcare and/or biotech industry. It can invest up to 25% of assets in companies in emerging markets. The Fund invests at least 80% of assets in equity securities and can invest up to 20% of assets in cash. It holds generally 40-70 securities in the portfolio.
Offer information
Type Description
Standard entry fee 4%
Indirect Cost Ratio (ICR) 2.40% (as at 30 Jun 2009)
Minimum initial investment $5,000.00
Minimum additional investments $1,000.00

Top 10 holdings (as at 31 Mar 2010)

Holding (as at 31 Mar 2010) Type % of Portfolio
Pfizer Inc. Stock 4.82%
Login now to view the complete list of holdings.

Fund data sourced from Morningstar. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only. Whilst every care has been taken in producing these numbers, neither Morningstar nor InvestSMART cannot make any guarantees around the complete accuracy of these figures. Should you decide to change investments, please read all relevant disclosure documents including the Product Disclosure Statements and if required, you may consider speaking to a financial professional for further guidance. A tax event may be realised as a result of switching investments. Past performance is not a reliable indicator of future performance.

How is your fund performing?

Out of the 5,494 Australian funds researched with a 10 year track record, 81% underperform the industry standard benchmarks by an average of 2.12%, with average fees of 1.79%^.

Compare your fund
Underperforming
81%^

Underperform the industry standard benchmarks

Compare your fund

Our Managed Funds

Returns Since Inception
InvestSMART International Equities 11.39%
Intelligent Investor Equity Growth 9.87%
InvestSMART High Growth 9.27%
Intelligent Investor Equity Income 9.06%
InvestSMART Diversified Property and Infrastructure 8.48%
InvestSMART Growth 8.47%
Intelligent Investor Australian Small Companies Fund 7.27%
InvestSMART Balanced 6.86%
InvestSMART Conservative 5.33%
InvestSMART Hybrid Income 5.27%
InvestSMART Interest Income 3.75%